The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
Open accessAbstract
Systemic lupus erythematosus (SLE) is a prototype systemic autoimmune disease characterized by flares of high morbidity. Using oligonucleotide microarrays, we now show that active SLE can be distinguished by a remarkably homogeneous gene expression pattern with overexpression of granulopoiesis-related and interferon (IFN)-induced genes. Using the most stringent statistical analysis (Bonferroni correction), 15 genes were found highly up-regulated in SLE patients, 14 of which are targets of IFN and one, defensin DEFA-3, a major product of immature granulocytes. A more liberal correction (Benjamini and Hochberg correction) yielded 18 additional genes, 12 of which are IFN-regulated and 4 granulocyte-specific. Indeed immature neutrophils were identified in a large fraction of SLE patients white blood cells. High dose glucocorticoids, a standard treatment of disease flares, shuts down the interferon signature, further supporting the role of this cytokine in SLE. The expression of 10 genes correlated with disease activity according to the SLEDAI. The most striking correlation (P < 0.001, r = 0.55) was found with the formyl peptide receptor-like 1 protein that mediates chemotactic activities of defensins. Therefore, while the IFN signature confirms the central role of this cytokine in SLE, microarray analysis of blood cells reveals that immature granulocytes may be involved in SLE pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunobiology of Dendritic Cells
Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.-J., Pulendran, B., & Palucka, K. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.767 · Cited by 6,634
Self-citationNasir, O. (2013) · Kidney and Blood Pressure Research · doi:10.1159/000350152 · Cited by 2,331
Casciola-Rosen, L. A., Anhalt, G., & Rosen, A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1317 · Cited by 1,717
Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus Erythematosus
Blanco, P., Palucka, A. K., Gill, M., Pascual, V., & Banchereau, J. (2001) · Science · doi:10.1126/science.1064890 · Cited by 1,266
Self-citationAnti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?
Feldmann, M., & Maini, R. N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.163 · Cited by 1,257
The Induction of Tolerance by Dendritic Cells That Have Captured Apoptotic Cells
Steinman, R. M., Turley, S., Mellman, I., & Inaba, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.3.411 · Cited by 1,172
Davidson, A., & Diamond, B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108023450506 · Cited by 1,042
Farkas, L., Beiske, K., Lund-Johansen, F., Brandtzaeg, P., & Jahnsen, F. L. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61689-6 · Cited by 730
Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity
Lipsky, P. E. (2001) · Nature Immunology · doi:10.1038/ni0901-764 · Cited by 695
Verhoven, B., Schlegel, R. A., & Williamson, P. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1597 · Cited by 666
Cited by
Items 101–160 of 160
Hua, J., Kirou, K., Lee, C., & Crow, M. K. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21890 · Cited by 317
Bauer, J. W., Baechler, E. C., Petri, M., Batliwalla, F. M., Crawford, D., Ortmann, W. A., Espe, K. J., Li, W., Patel, D. D., Gregersen, P. K., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030491 · Cited by 313
The innate immune system in SLE: type I interferons and dendritic cells
Rönnblom, L., & Pascual, V (2008) · Lupus · doi:10.1177/0961203308090020 · Cited by 312
Self-citationBaechler, E. C., Bauer, J. W., Slattery, C. A., Ortmann, W. A., Espe, K. J., Novitzke, J., Ytterberg, S. R., Gregersen, P. K., Behrens, T. W., & Reed, A. M. (2007) · Molecular Medicine · doi:10.2119/2006-00085.baechler · Cited by 311
Walsh, R. J., Kong, S. W., Yao, Y., Jallal, B., Kiener, P. A., Pinkus, J. L., Beggs, A. H., Amato, A. A., & Greenberg, S. A. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22928 · Cited by 310
Altered B cell signalling in autoimmunity
Rawlings, D. J., Metzler, G., Wray-Dutra, M., & Jackson, S. W. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.24 · Cited by 308
Type I interferon in rheumatic diseases
Muskardin, T. L. W., & Niewold, T. B. (2018) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2018.31 · Cited by 308
Type I Interferon: Potential Therapeutic Target for Psoriasis?
Yao, Y., Richman, L., Morehouse, C., de los Reyes, M., Higgs, B. W., Boutrin, A., White, B., Coyle, A., Krueger, J., Kiener, P. A., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002737 · Cited by 308
Hu, X., Chakravarty, S. D., & Ivashkiv, L. B. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00707.x · Cited by 303
Type I interferon in the pathogenesis of systemic lupus erythematosus
Postal, M., Vivaldo, J. F., Fernandez-Ruiz, R., Paredes, J. L., Appenzeller, S., & Niewold, T. B. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.10.014 · Cited by 306
Role of STAT3 in Type I Interferon Responses
Ho, H. H., & Ivashkiv, L. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511797200 · Cited by 302
The Role of Epigenetics in Autoimmune/Inflammatory Disease
Surace, A. E. A., & Hedrich, C. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01525 · Cited by 302
Stagakis, E., Bertsias, G., Verginis, P., Nakou, M., Hatziapostolou, M., Kritikos, H., Iliopoulos, D., & Boumpas, D. T. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.139857 · Cited by 301
Bauer, J. W., Petri, M., Batliwalla, F. M., Koeuth, T., Wilson, J., Slattery, C., Panoskaltsis‐Mortari, A., Gregersen, P. K., Behrens, T. W., & Baechler, E. C. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24803 · Cited by 297
He, B., Qiao, X., & Cerutti, A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.7.4479 · Cited by 296
The interferon signature in autoimmune diseases
Rönnblom, L., & Eloranta, M.-L. (2013) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32835c7e32 · Cited by 294
Autoimmunity through Cytokine-Induced Dendritic Cell Activation
Banchereau, J., Pascual, V., & Palucka, A. K. (2004) · Immunity · doi:10.1016/s1074-7613(04)00108-6 · Cited by 293
Self-citationType I Interferons in Autoimmune Disease
Crow, M. K., Olferiev, M., & Kirou, K. A. (2019) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043952 · Cited by 291
Obermoser, G., Presnell, S., Domico, K., Xu, H., Wang, Y., Anguiano, E., Thompson-Snipes, L., Ranganathan, R., Zeitner, B., Bjork, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.12.008 · Cited by 289
Self-citationBurke, J. R., Cheng, L., Gillooly, K. M., Strnad, J., Zupa-Fernandez, A., Catlett, I. M., Zhang, Y., Heimrich, E. M., McIntyre, K. W., Cunningham, M. D., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw1736 · Cited by 289
Microarray Analysis of Interferon-regulated Genes in SLE
Crow, M. K., Kirou, K. A., & Wohlgemuth, J. (2003) · Autoimmunity · doi:10.1080/08916930310001625952 · Cited by 287
Systemic lupus erythematosus: all roads lead to type I interferons
Pascual, V., Farkas, L., & Banchereau, J. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.09.014 · Cited by 285
Self-citationNeutrophils in innate and adaptive immunity
Jaillon, S., Galdiero, M. R., Del Prete, D., Cassatella, M. A., Garlanda, C., & Mantovani, A. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0374-8 · Cited by 285
Barrat, F. J., Meeker, T., Chan, J. H., Guiducci, C., & Coffman, R. L. (2007) · European Journal of Immunology · doi:10.1002/eji.200737815 · Cited by 284
Yao, Y., Richman, L., Higgs, B. W., Morehouse, C. A., de los Reyes, M., Brohawn, P., Zhang, J., White, B., Coyle, A. J., Kiener, P. A., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24557 · Cited by 284
Cell-Free DNA as a Biomarker in Autoimmune Rheumatic Diseases
Duvvuri, B., & Lood, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00502 · Cited by 282
Denny, M. F., Thacker, S., Mehta, H., Somers, E. C., Dodick, T., Barrat, F. J., McCune, W. J., & Kaplan, M. J. (2007) · Blood · doi:10.1182/blood-2007-05-089086 · Cited by 282
de Jesus, A. A., Canna, S. W., Liu, Y., & Goldbach-Mansky, R. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112227 · Cited by 282
The regulation of inflammation by interferons and their STATs
Rauch, I., Müller, M., & Decker, T. (2013) · JAK-STAT · doi:10.4161/jkst.23820 · Cited by 281
Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model
Rowland, S. L., Riggs, J. M., Gilfillan, S., Bugatti, M., Vermi, W., Kolbeck, R., Unanue, E. R., Sanjuan, M. A., & Colonna, M. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20132620 · Cited by 281
The Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition
He, H.-Q., & Ye, R. (2017) · Molecules · doi:10.3390/molecules22030455 · Cited by 279
Mistry, P., Nakabo, S., O’Neil, L., Goel, R. R., Jiang, K., Carmona-Rivera, C., Gupta, S., Chan, D. W., Carlucci, P. M., Wang, X., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908576116 · Cited by 278
Macri, C., Pang, E. S., Patton, T., & O’Keeffe, M. (2018) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2017.12.009 · Cited by 275
Human neutrophils in the saga of cellular heterogeneity: insights and open questions
Scapini, P., Marini, O., Tecchio, C., & Cassatella, M. A. (2016) · Immunological Reviews · doi:10.1111/imr.12448 · Cited by 274
Savarese, E., Chae, O.-W., Trowitzsch, S., Weber, G., Kastner, B., Akira, S., Wagner, H., Schmid, R. M., Bauer, S., & Krug, A. (2006) · Blood · doi:10.1182/blood-2005-07-2650 · Cited by 271
Mathian, A., Weinberg, A., Gallegos, M., Banchereau, J., & Koutouzov, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2499 · Cited by 270
Self-citationBlanco, P., Pitard, V., Viallard, J., Taupin, J., Pellegrin, J., & Moreau, J. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20745 · Cited by 265
Type I interferons: crucial participants in disease amplification in autoimmunity
Hall, J. C., & Rosen, A. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.237 · Cited by 265
Luo, X., Yang, W., Ye, D.-Q., Cui, H., Zhang, Y., Hirankarn, N., Qian, X., Tang, Y., Lau, Y. L., de Vries, N., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002128 · Cited by 262
Tissue-resident macrophages are locally programmed for silent clearance of apoptotic cells
Roberts, A. W., Lee, B. L., Deguine, J., John, S., Shlomchik, M. J., & Barton, G. M. (2017) · Immunity · doi:10.1016/j.immuni.2017.10.006 · Cited by 261
Tan, F. K., Zhou, X., Mayes, M. D., Gourh, P., Guo, X., Marcum, C., Jin, L., & Arnett, F. C. (2006) · Rheumatology · doi:10.1093/rheumatology/kei244 · Cited by 260
Fernandez, D. R., Telarico, T., Bonilla, E., Li, Q., Banerjee, S., Middleton, F. A., Phillips, P. E., Crow, M. K., Oess, S., Muller-Esterl, W., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803600 · Cited by 257
Development and selection of marginal zone B cells
Lopes‐Carvalho, T., & Kearney, J. F. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.0112.x · Cited by 253
Assessing the human immune system through blood transcriptomics
Chaussabel, D., Pascual, V., & Banchereau, J. (2010) · BMC Biology · doi:10.1186/1741-7007-8-84 · Cited by 252
Self-citationThe interferon-α signature of systemic lupus erythematosus
Obermoser, G., & Pascual, V. (2010) · Lupus · doi:10.1177/0961203310371161 · Cited by 220
Self-citationGene expression changes in children with autism
Gregg, J. P., Lit, L., Baron, C. A., Hertz-Picciotto, I., Walker, W., Davis, R. A., Croen, L. A., Ozonoff, S., Hansen, R., Pessah, I. N., et al. (2008) · Genomics · doi:10.1016/j.ygeno.2007.09.003 · Cited by 181
Smith, J. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00422 · Cited by 168
Ncf1 polymorphism reveals oxidative regulation of autoimmune chronic inflammation
Holmdahl, R., Sareila, O., Olsson, L. M., Bäckdahl, L., & Wing, K. (2016) · Immunological Reviews · doi:10.1111/imr.12378 · Cited by 131
Minireview: glucocorticoids in autoimmunity: unexpected targets and mechanisms
Flammer, J. R., & Rogatsky, I. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-0068 · Cited by 140
The neutrophil: constant defender and first responder
Fine, N., Tasevski, N., McCulloch, C. A., Tenenbaum, H. C., & Glogauer, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.571085 · Cited by 115
Bacterial amyloid curli acts as a carrier for DNA to elicit an autoimmune response via TLR2 and TLR9
Tursi, S. A., Lee, E. Y., Medeiros, N. J., Lee, M. H., Nicastro, L. K., Buttaro, B., Gallucci, S., Wilson, R. P., Wong, G. C. L., & Tükel, Ç. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006315 · Cited by 115
Therapeutic potential of targeting TBK1 in autoimmune diseases and interferonopathies
Hasan, M., & Yan, N. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.04.008 · Cited by 83
Ortmann, W., & Kolaczkowska, E. (2018) · Cell and Tissue Research · doi:10.1007/s00441-017-2751-4 · Cited by 80
Crispín, J. C., Apostolidis, S. A., Rosetti, F., Keszei, M., Wang, N., Terhorst, C., Mayadas, T. N., & Tsokos, G. C. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200143 · Cited by 64
Hikami, K., Kawasaki, A., Ito, I., Koga, M., Ito, S., Hayashi, T., Matsumoto, I., Tsutsumi, A., Kusaoi, M., Takasaki, Y., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30188 · Cited by 58
Carter, V., LaCava, J., Taylor, M. S., Liang, S. Y., Mustelin, C., Ukadike, K. C., Bengtsson, A., Lood, C., & Mustelin, T. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41054 · Cited by 41
Janus‐like effects of type I interferon in autoimmune diseases
Axtell, R. C., & Raman, C. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01131.x · Cited by 47
Lauwerys, B. R., & Wakeland, E. K. (2005) · Lupus · doi:10.1191/0961203305lu2052oa · Cited by 42
T-cell exhaustion: understanding the interface of chronic viral and autoinflammatory diseases
McKinney, E. F., & Smith, K. G. (2016) · Immunology & Cell Biology · doi:10.1038/icb.2016.81 · Cited by 36
Sawai, C. M., Serpas, L., Neto, A. G., Jang, G., Rashidfarrokhi, A., Kolbeck, R., Sanjuan, M. A., Reizis, B., & Sisirak, V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02475 · Cited by 20
“For instance, systemic lupus erythematous (SLE) patients (10, 11) have an accumulation of IFN-I-producing pDCs in the affected tissues, which likely contributes to the increased expression in IFN-I-inducible genes and overall “IFN-I signature” characteristic of SLE.”
Background
Metadata
- Authors
- Bennett, L., Palucka, A. K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J., & Pascual, V.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2003-03-17
- Volume
- 197
- Issue
- 6
- Pages
- 711-723
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2168888135
- Cited by
- 1,958
- References
- 38
- FWCI
- 43.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.